000 05070cam a2200541Mi 4500
001 9781003043164
003 FlBoTFG
005 20220711212437.0
006 m o d
007 cr |n|||||||||
008 210716s2021 flu ob 001 0 eng d
040 _aOCoLC-P
_beng
_cOCoLC-P
020 _a9781000421606
_q(electronic bk.)
020 _a1000421600
_q(electronic bk.)
020 _a9781000422351
_q(ePub ebook)
020 _a1000422356
020 _a9781003043164
_q(ebook)
020 _a100304316X
020 _z9780367488451
020 _z0367488450
020 _z9781032050720
020 _z1032050721
024 7 _a10.1201/9781003043164
_2doi
035 _a(OCoLC)1260292653
035 _a(OCoLC-P)1260292653
050 4 _aRM301.25
072 7 _aTEC
_x059000
_2bisacsh
072 7 _aTBN
_2bicssc
082 0 4 _a615.19
_223
245 0 0 _aMicro and nanotechnologies based product development
_h[electronic resource] /
_cedited by Neelesh Kumar Mehra and Arvind Gulbake.
250 _aFirst edition.
264 1 _aBoca Raton :
_bCRC Press,
_c2021.
300 _a1 online resource
336 _atext
_2rdacontent
336 _astill image
_2rdacontent
337 _acomputer
_2rdamedia
338 _aonline resource
_2rdacarrier
520 _aThis book provides comprehensive information of the nanotechnology-based pharmaceutical product development including a diverse range of arenas such as liposomes, nanoparticles, fullerenes, hydrogels, thermally responsive externally activated theranostics (TREAT), hydrogels, microspheres, micro- and nanoemulsions and carbon nanomaterials. It covers the micro- and nanotechnological aspects for pharmaceutical product development with the product development point of view and also covers the industrial aspects, novel technologies, stability studies, validation, safety and toxicity profiles, regulatory perspectives, scale-up technologies and fundamental concept in the development of products. Salient Features: Covers micro- and nanotechnology approaches with current trends with safety and efficacy in product development. Presents an overview of the recent progress of stability testing, reverse engineering, validation and regulatory perspectives as per regulatory requirements. Provides a comprehensive overview of the latest research related to micro- and nanotechnologies including designing, optimisation, validation and scale-up of micro- and nanotechnologies. Is edited by two well-known researchers by contribution of vivid chapters from renowned scientists across the globe in the field of pharmaceutical sciences. Dr. Neelesh Kumar Mehra is working as an Assistant Professor of Pharmaceutics & Biopharmaceutics at the Department of Pharmaceutics, National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad, India. He received TEAM AWARD' for successful commercialisation of an ophthalmic suspension product. He has authored more than 60 peer-reviewed publications in highly reputed international journals and more than 10 book chapter contributions. He has filed patents on manufacturing process and composition to improved therapeutic efficacy for topical delivery. He guided PhD and MS students for their dissertations/research projects. He has received numerous outstanding awards including Young Scientist Award and Team Award for his research output. He recently published one edited book, Dendrimers in Nanomedicine: Concept, Theory and Regulatory Perspectives', in CRC Press. Currently, he is editing books on nano drug delivery-based products with Elsevier Pvt Ltd. He has rich research and teaching experience in the formulation and development of complex, innovative ophthalmic and injectable biopharmaceutical products including micro- and nanotechnologies for regulated market. Dr. Arvind Gulbake is working as an Assistant Professor at the Faculty of Pharmacy, School of Pharmaceutical & Population Health Informatics, at DIT University, Dehradun, India. He has authored more than 40 peer-reviewed publications in highly reputed international journals, four book chapters and a patent contribution. He has received outstanding awards including Young Scientist Award and BRG Travel Award for his research. He is an assistant editor for IJAP. He guided PhD and MS students for their dissertations/research projects. He has successfully completed extramural project funded by SERB, New Delhi, Government of India. He has more than 12 years of research and teaching experience in the formulation and development of nanopharmaceuticals.
588 _aOCLC-licensed vendor bibliographic record.
650 0 _aPharmaceutical technology.
_97812
650 0 _aNanomedicine.
_95252
650 0 _aBiomedical engineering.
_93292
700 1 _aMehra, Neelesh Kumar,
_eeditor.
_916595
700 1 _aGulbake, Arvind,
_eeditor.
_916596
856 4 0 _3Taylor & Francis
_uhttps://www.taylorfrancis.com/books/9781003043164
856 4 2 _3OCLC metadata license agreement
_uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
942 _cEBK
999 _c71294
_d71294